President of Russia
  • Events
  • Structure
  • Videos and Photos
  • Documents
  • Contacts
  • Search
  • Search this website
President of Russia
Mobile version

President's
website
sections

  • Events
  • Structure
  • Videos and Photos
  • Documents
  • Contacts
  • Search
  • Search
  • For the Media
  • Subscribe
  • Directory
  • Version for People with Disabilities
  • YouTube Channel
  • Русский

President's
website
resources

  • President of RussiaCurrent resource
  • The Constitution of Russia
  • State Insignia
  • Send a Letter
  • Vladimir Putin’s Personal Website

Special
animal welfare
projects

  • Amur tiger
  • Beluga whale
  • Polar bear
  • Snow leopard
  • Far Eastern leopard

Legal
and technical
information

  • About website
  • Using website content
  • Personal data of website users
  • Contact website team

All content on this site is licensed under

Creative Commons Attribution 4.0 International

Presidential Executive Office2023

The 2019 National Awards in Science and Technology have been conferred on Dmitry Morozov, Andrei Ulitin, and Tatyana Chernovskaya for developing and introducing into clinical practice a complex of medicinal preparations based on monoclonal antibodies to treat cancer and autoimmune diseases

June 18, 2020

Dmitry Morozov was born on February 1, 1965 in Moscow and is Director General of BIOCAD.

Andrei Ulitin was born on April 3, 1974 in Kuibyshev and is Acting Research Fellow at the Institute for Biological Instrumentation of the Russian Academy of Sciences.

Tatyana Chernovskaya was born on August 12, 1951 in Sosnogorsk, Komi ASSR. BSc, Director of the Biochemistry Department at BIOCAD.

For the first time in Russia, researchers have created a unique scientific and industrial complex of ready dosage forms of monoclonal antibodies to treat malignant and autoimmune diseases, which fully meets Russia’s needs. The biotechnological (MabNext) and bioinformatical (YLab) platforms they developed surpass their foreign analogues and allow faster production of immunotherapeutic medicines, which makes medical aid more readily available.

Dmitry Morozov founded the only scientific and industrial complex to develop and produce monoclonal antibodies in Russia, which is also the first in Eastern Europe. He is the ideologist of the biotechnological (MabNext) and bioinformatical (YLab) platforms.

Andrei Ulitin is a major expert in the genetic engineering of expression systems and the production of therapeutic monoclonal antibodies. He directed the creation of the MabNext biotechnological platform that helps to quickly develop medical agents from concept to pre-clinical trial (over the last four years, three drugs were developed and implemented in Russia and another two have passed state registration trials).

Tatyana Chernovskaya is a leading specialist in the biochemistry of protein compounds. She directly led the development of technologies to isolate high purity proteins and monoclonal antibodies for medicines.

See also

Winners of 2019 Russian Federation National Awards announced
June 18, 2020
Presentation of Russian Federation National Awards
June 24, 2020
Text

Share
Direct link
http://en.kremlin.ru/supplement/5525
Share
  • VK
  • LiveJournal
  • Send by email
  • Print
Send by email

Official Website of the President of Russia:

The 2019 National Awards in Science and Technology have been conferred on Dmitry Morozov, Andrei Ulitin, and Tatyana Chernovskaya for developing and introducing into clinical practice a complex of medicinal preparations based on monoclonal antibodies to treat cancer and autoimmune diseases

http://en.kremlin.ru/supplement/5525

Last updated at June 18, 2020, 15:33

Официальные сетевые ресурсы

Президента России

Official Internet Resources

of the President of Russia

Русский Английский
  • For the Media
  • Version for People with Disabilities
  • Telegram channel
  • YouTube Channel
  • State Insignia
  • Send a Letter
  • Vladimir Putin’s Personal Website
  • Putin. 20 years

Presidential Executive Office
2023